Speech and Language Disorder Market is expected to reach US$ 12.90 billion by 2030

Publisher: The Insight Partners

Software Held Larger Speech and Language Disorder Market Share in 2022

According to our new research study on "Speech and Language Disorder Market Forecast to 2030 – Global Analysis – by Type, Cause, Disorder Type, Category, and Provider," the market is expected to grow from US$ 8.39 billion in 2022 to US$ 12.90 billion by 2030; it is anticipated to record a CAGR of 5.7% from 2022 to 2030. The speech and language disorder market report emphasizes the trends prevalent in the global market, along with drivers and deterrents affecting its growth.

The growing prevalence of speech and language disorders and increasing cases of neurodegenerative diseases and stroke propel the market growth. However, the unavailability of speech therapy in underdeveloped or remote areas and the lack of healthcare professionals are hampering the growth of the market. The use of artificial intelligence for speech and language therapy is expected to bring new speech and language disorder market trends in the coming years.

Speech and Language Disorder Market, by Region, 2022 (%)

To get sample Copy of the report, along with the TOC, Statistics, and Tables please visit @ https://www.theinsightpartners.com/sample/TIPRE00038993

Source: The Insight Partners Analysis

Increasing Cases of Diseases Affecting Speech and Language Propels Speech and Language Disorder Market Growth

Conditions such as stroke and neurodegenerative diseases can affect the motor function of the mouth, resulting in speech and language disorders in people. Parkinson's disease is the second-most common neurodegenerative disease after Alzheimer's disease, associated with cognitive impairment and motor control abnormalities. According to the World Health Organization (WHO) report published in 2022, the prevalence of PD has doubled in the last 25 years, affecting ~1% of the global population aged more than 60 years. According to the Parkinson's Foundation data, in 2022, ~1 million people in the US are living with PD, and it is expected to reach 1.2 million by 2030. As per the same source, more than 10 million people are living with PD globally, and about 4% of the diagnosed cases are aged below 50. Dysarthria and aphasia are common speech disorders occurring in patients suffering from PD. According to the National Library of Medicine, about 90% of patients suffering from PD will develop dysarthria during the disease period.

As per the Burden of Stroke in Europe report conducted by King's College London for the Stroke Alliance for Europe, the incidence of stroke is likely to reach 35% in Spain, and its prevalence will rise to 31% by the end of 2035. According to IntechOpen, stroke is the fifth leading death cause in the US, and about one stroke occurs approximately every 40 seconds, and stroke-related death occurs roughly every 4 minutes. According to the study published by Elsevier, in China, 17.8 million cases of stroke, 3.4 million new strokes, and 2.3 million stroke-related deaths were reported in 2020. Thus, the speech and language disorder market size is likely to continue to surge due to the increasing prevalence of neurodegenerative diseases, such as PD and stroke.

The speech and language disorder market, by type, is bifurcated into hardware and software. The software segment is further divided into web-based and app-based. In 2022, the software segment held a larger share of the market and is expected to record a higher CAGR during 2022–2030. The increasing use of telehealth technologies for therapies is mainly fueling the speech and language disorder market growth for the software segment.

Based on cause, the market is segmented into stroke, injury, neurodegenerative diseases, and others. The neurodegenerative diseases segment is further divided into Parkinson's disease, amyotrophic lateral sclerosis, and Huntington's disease. In 2022, the stroke segment held the largest speech and language disorder market share. However, the neurodegenerative diseases segment is expected to record the highest CAGR during 2022–2030. The increasing prevalence of stroke due to the growing number of obesity, diabetes, and hypertension cases globally is propelling the growth of the stroke segment.

Based on disorder type, the market is divided into articulation disorders, phonological disorders, voice disorders or resonance disorders, language disorders, and others. In 2022, the articulation disorders segment held the largest share of the speech and language disorder market and is expected to record the highest CAGR during 2022–2030.

Based on category, the speech and language disorder market is bifurcated into adults and pediatrics. In 2022, the pediatrics segment held a larger share of the market and is expected to record a higher CAGR during 2022–2030. As per the National Institute on Deafness and Other Communication Diseases, the prevalence of speech sound disorders such as articulation disorder and phonological disorder is about 8–9% in young children, and about 3.3% of the total US children aged between 3 and 17 years have language disorder. Thus, the prevalence of speech disorders in children is propelling the growth of the segment.

The market, by provider, is segmented into healthcare facilities, speech therapy centers, rehabilitation centers, and others. In 2022, the healthcare facilities segment held the largest share of the speech market and is expected to record the highest CAGR during 2022–2030.

The speech and language disorder market analysis has been carried out by considering the following segments: type, cause, disorder type, category, and provider. The speech and language disorder market, by type, is bifurcated into hardware and software. The software segment is further segmented into web-based and app-based. Based on cause, the market is segmented into stroke, injury, neurodegenerative diseases, and others. The neurodegenerative diseases segment is further divided into Parkinson's disease, ALS, and Huntington's disease. In terms of disorder type, the market is divided into articulation disorders, phonological disorders, voice disorders or resonance disorders, language disorders, and others.

Based on category, the speech and language disorder market is segmented into adults and pediatrics. The market, by provider, is segmented into healthcare facilities, speech therapy centers, rehabilitation centers, and others. The scope of speech and language disorder market report includes the assessment of the market performance in North America (the US, Canada, and Mexico), Europe (Spain, the UK, Germany, France, Italy, and the Rest of Europe), Asia Pacific (South Korea, China, India, Japan, Australia, and the Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

Contact Us
Contact Person: Content Team 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com